61
Participants
Start Date
April 28, 2022
Primary Completion Date
March 13, 2024
Study Completion Date
March 13, 2024
VIS171
Participants will receive VIS171 via SC route of administration.
Placebo
Participants will receive Placebo via SC route of administration
Ambulatory for Specialized Medical Help - skin and venereal diseases, Sofia
Comac Medical Ltd, Sofia
MBAL Sveta Sofia, Sofia
Diagnostic and Consultative Center Convex EOOD, Sofia
UMHAT, Plovdiv
Radboud University Medical Center, Gelderland
New Zealand Clinical Research, Christchurch
Universitaetsklinikum Bonn AöR, Bonn
Universitätsmedizin der Johannes-Gutenberg-Universität Mainz, Rheinland-Pfalz
Clinical republican Hospital, Chisinau
Visterra, Inc.
INDUSTRY